---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-071721"
form_type: "8-K"
ticker: "MLTX"
cik: "0001821586"
company_name: "MoonLake Immunotherapeutics"
filed_at: "2026-06-25T10:18:36+00:00"
generated_at: "2026-06-25T10:20:11.191985+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# MoonLake Immunotherapeutics launches $200M public offering of 9M shares at $20.00 each

## Summary
- Offering consists of 9,000,000 Class A ordinary shares at $20.00/share plus pre-funded warrants for up to 1,000,000 shares at $19.9999 each.
- Underwriters granted 30-day option to purchase up to 1,500,000 additional shares at the offering price less discounts.
- Gross proceeds expected to be $200 million before underwriting discounts and offering expenses.
- Offering expected to close June 25, 2026; securities sold under effective shelf registration statement (File No. 333-274286).
- Pre-funded warrants exercisable immediately at $0.0001/share, subject to beneficial ownership limitations (4.99% default).

## SEC filing metadata
- accession: 0001213900-26-071721
- form_type: 8-K
- ticker: MLTX
- cik: 0001821586
- company_name: MoonLake Immunotherapeutics
- filed_at: 2026-06-25T10:18:36+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1821586/000121390026071721/0001213900-26-071721-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1821586/000121390026071721/ea0295766-8k_moonlake.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-071721
- JSON: https://secwatch.observer/filing/0001213900-26-071721.json
- Plain text: https://secwatch.observer/filing/0001213900-26-071721.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.